After-hours movers: GitLab surges on earnings, EyePoint adds to intra-day gains

This post was originally published on this site

https://i-invdn-com.investing.com/news/LYNXNPEC3B0CQ_M.jpg

Gitlab Inc (NASDAQ:GTLB) 17% HIGHER; issues a strong beat-and-raise third quarter.

Amarin Corporation plc (NASDAQ:AMRN) 12% HIGHER; Sarissa Capital raised its stake and said it believes the stock is “significantly undervalued.”

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) 9% HIGHER; adds to today’s 177% intra-day gains related to positive wet AMD treatment trial data. After the close, the company announced that it has commenced an underwritten public offering of $175 million of shares of its common stock.

Integral Ad Science Holding LLC (NASDAQ:IAS) 8% LOWER; announced the commencement of a public offering of its common stock by investment funds affiliated with Vista Equity Partners

SpringWorks Therapeutics, Inc. (Nasdaq: SWTX) 5% LOWER; commenced an underwritten public offering of $250.0 million of shares of its common stock.

Apellis Pharmaceuticals (NASDAQ:APLS) 2% HIGHER; BofA Securities upgraded the stock from Neutral to Buy with a price target of $85.00 (from $52.00).